Please wait while the formulary information is being retrieved.
Drug overview for KETOCONAZOLE (ketoconazole):
Generic name: KETOCONAZOLE (kee-toe-CON-uh-zole)
Drug class: Topical Antifungals
Therapeutic class: Dermatological
Ketoconazole, a synthetic azole antifungal agent, is an imidazole derivative.
No enhanced Uses information available for this drug.
Generic name: KETOCONAZOLE (kee-toe-CON-uh-zole)
Drug class: Topical Antifungals
Therapeutic class: Dermatological
Ketoconazole, a synthetic azole antifungal agent, is an imidazole derivative.
No enhanced Uses information available for this drug.
DRUG IMAGES
KETOCONAZOLE 2% CREAM
The following indications for KETOCONAZOLE (ketoconazole) have been approved by the FDA:
Indications:
Cutaneous candidiasis
Fungal infection of skin
Seborrheic dermatitis
Tinea corporis
Tinea cruris
Tinea pedis
Tinea versicolor
Professional Synonyms:
Corporeal ringworm
Cutaneous candidosis
Cutaneous moniliasis
Dermatitis seborrheica
Dermatomycosis pedis
Dermatomycosis
Dhobie itch
Dyssebacea
Dyssebacia
Eczema marginatum
Fungal dermatologic infection
Fungal skin infection
Jock itch
Pityriasis versicolor
Seborrhea corporis
Seborrheic eczema
Tinea circinata
Tinea furfuracea
Tinea glabrosa
Tinea inguinalis
Tinea of the foot
Unna's disease
Indications:
Cutaneous candidiasis
Fungal infection of skin
Seborrheic dermatitis
Tinea corporis
Tinea cruris
Tinea pedis
Tinea versicolor
Professional Synonyms:
Corporeal ringworm
Cutaneous candidosis
Cutaneous moniliasis
Dermatitis seborrheica
Dermatomycosis pedis
Dermatomycosis
Dhobie itch
Dyssebacea
Dyssebacia
Eczema marginatum
Fungal dermatologic infection
Fungal skin infection
Jock itch
Pityriasis versicolor
Seborrhea corporis
Seborrheic eczema
Tinea circinata
Tinea furfuracea
Tinea glabrosa
Tinea inguinalis
Tinea of the foot
Unna's disease
The following dosing information is available for KETOCONAZOLE (ketoconazole):
No enhanced Dosing information available for this drug.
Ketoconazole is applied topically to the skin as a 2% cream, foam, gel, or shampoo. Ketoconazole is applied topically to the hair and scalp as a 1% shampoo. The drug also has been applied topically to hair+ and scalp+ as a 2% shampoo.
Ketoconazole topical cream, foam, gel, and shampoo are for external use only. These topical preparations should not be applied to the eyes and should not be administered orally or intravaginally. If contact with eyes, mouth, or vagina occurs, the exposed areas should be rinsed thoroughly with water.
Fire, flame, and/or smoking should be avoided during and immediately after application of ketoconazole 2% foam or gel. (See Cautions: Precautions and Contraindications.)
Ketoconazole topical cream, foam, gel, and shampoo are for external use only. These topical preparations should not be applied to the eyes and should not be administered orally or intravaginally. If contact with eyes, mouth, or vagina occurs, the exposed areas should be rinsed thoroughly with water.
Fire, flame, and/or smoking should be avoided during and immediately after application of ketoconazole 2% foam or gel. (See Cautions: Precautions and Contraindications.)
| DRUG LABEL | DOSING TYPE | DOSING INSTRUCTIONS |
|---|---|---|
| KETOCONAZOLE 2% CREAM | Maintenance | Adults apply to the affected area(s) by topical route once daily |
| DRUG LABEL | DOSING TYPE | DOSING INSTRUCTIONS |
|---|---|---|
| KETOCONAZOLE 2% CREAM | Maintenance | Adults apply to the affected area(s) by topical route once daily |
The following drug interaction information is available for KETOCONAZOLE (ketoconazole):
There are 0 contraindications.
There are 0 severe interactions.
There are 0 moderate interactions.
The following contraindication information is available for KETOCONAZOLE (ketoconazole):
Drug contraindication overview.
No enhanced Contraindications information available for this drug.
No enhanced Contraindications information available for this drug.
There are 0 contraindications.
There are 0 severe contraindications.
There are 1 moderate contraindications.
Clinically significant contraindication, where the condition can be managed or treated before the drug may be given safely.
| Moderate List |
|---|
| No disease contraindications |
The following adverse reaction information is available for KETOCONAZOLE (ketoconazole):
Adverse reaction overview.
No enhanced Common Adverse Effects information available for this drug.
No enhanced Common Adverse Effects information available for this drug.
There are 2 severe adverse reactions.
| More Frequent | Less Frequent |
|---|---|
| None. | None. |
| Rare/Very Rare |
|---|
|
Anaphylaxis Angioedema |
There are 12 less severe adverse reactions.
| More Frequent | Less Frequent |
|---|---|
|
Pruritus of skin Skin inflammation Skin irritation |
None. |
| Rare/Very Rare |
|---|
|
Abnormal hair texture Alopecia Cheilitis Dermatitis due to topical drug Dry skin Erythema Hair discoloration Skin rash Stinging of skin |
The following precautions are available for KETOCONAZOLE (ketoconazole):
No enhanced Pediatric Use information available for this drug.
Contraindicated
Severe Precaution
Management or Monitoring Precaution
Contraindicated
| None |
Severe Precaution
| None |
Management or Monitoring Precaution
| None |
No enhanced Pregnancy information available for this drug.
No enhanced Lactation information available for this drug.
No enhanced Geriatric Use information available for this drug.
The following prioritized warning is available for KETOCONAZOLE (ketoconazole):
No warning message for this drug.
No warning message for this drug.
The following icd codes are available for KETOCONAZOLE (ketoconazole)'s list of indications:
| Cutaneous candidiasis | |
| B37.2 | Candidiasis of skin and nail |
| Fungal infection of skin | |
| B35 | Dermatophytosis |
| B35.0 | Tinea barbae and tinea capitis |
| B35.1 | Tinea unguium |
| B35.2 | Tinea manuum |
| B35.3 | Tinea pedis |
| B35.4 | Tinea corporis |
| B35.5 | Tinea imbricata |
| B35.6 | Tinea cruris |
| B35.8 | Other dermatophytoses |
| B35.9 | Dermatophytosis, unspecified |
| B36 | Other superficial mycoses |
| B36.0 | Pityriasis versicolor |
| B36.1 | Tinea nigra |
| B36.2 | White piedra |
| B36.3 | Black piedra |
| B36.8 | Other specified superficial mycoses |
| B36.9 | Superficial mycosis, unspecified |
| B37.2 | Candidiasis of skin and nail |
| B37.31 | Acute candidiasis of vulva and vagina |
| B37.32 | Chronic candidiasis of vulva and vagina |
| Seborrheic dermatitis | |
| L21 | Seborrheic dermatitis |
| L21.0 | Seborrhea capitis |
| L21.1 | Seborrheic infantile dermatitis |
| L21.8 | Other seborrheic dermatitis |
| L21.9 | Seborrheic dermatitis, unspecified |
| Tinea corporis | |
| B35.4 | Tinea corporis |
| Tinea cruris | |
| B35.6 | Tinea cruris |
| Tinea pedis | |
| B35.3 | Tinea pedis |
| Tinea versicolor | |
| B36.0 | Pityriasis versicolor |
Formulary Reference Tool